Pembanding Perusahaan
Analisis berdampingan posisi rantai pasokan, sinyal institusional, dan skor kesenjangan berita.
Tingkat Kapitalisasi Pasar
Peran Rantai
Skor Kesenjangan
Aktivitas IB
Perbandingan bauran pendapatan
Tentang
Eli Lilly is the world's most valuable pharmaceutical company, propelled by the blockbuster GLP-1 receptor agonist tirzepatide (Mounjaro/Zepbound) for diabetes and obesity. Its Alzheimer's antibody donanemab and strong oncology pipeline give it one of the most promising drug portfolios in the industry.
Didirikan
1876
Karyawan
43,000+
Kantor Pusat
Indianapolis, Indiana, USA
Pendapatan
$52.8B
Sinyal kesenjangan berita
Aktivitas IB: HIGH
Sinyal institusional
BlackRock
2024-08-13
BlackRock
2024-08-13
BlackRock
2024-08-13
Pola kaskade
Hubungan kunci
Tentang
Novo Nordisk is the global leader in diabetes care and has become a GLP-1 giant with Ozempic and Wegovy. The obesity-drug revolution has made it Europe's most valuable company. Its near-monopoly on injectable semaglutide positions it at the center of the $100B+ weight-loss drug market.
Didirikan
1923
Karyawan
64,000+
Kantor Pusat
Bagsvaerd, Denmark
Pendapatan
$42.6B
Sinyal kesenjangan berita
Aktivitas IB: HIGH
Sinyal institusional
BlackRock
2024-08-13
BlackRock
2024-08-13
BlackRock
2024-08-13